行情

NURO

NURO

NeuroMetrix
NASDAQ

实时行情|Nasdaq Last Sale

0.3698
-0.0150
-3.90%
休市 16:00 09/20 EDT
开盘
0.3848
昨收
0.3848
最高
0.3975
最低
0.3698
成交量
5.97万
成交额
--
52周最高
1.386
52周最低
0.3200
市值
361.73万
市盈率(TTM)
-0.7013
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NURO 新闻

  • 周末要闻:美股终结三周连涨 埃及股市暴跌触发熔断
  • 新浪美股.1小时前
  • 外盘头条:特朗普再次呼吁美联储将利率降至零以下
  • 新浪美股.2小时前
  • 华为苹果正面交锋 同时发布新品谁主沉浮?
  • 证券日报.4小时前
  • 德国银行业协会预计该国GDP增长率为0.5%
  • 新浪美股.6小时前

更多

所属板块

医疗设备、用品及经销
+0.15%
医疗设备和用品
-0.22%

热门股票

名称
价格
涨跌幅

NURO 简况

NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.
展开

Webull提供Neurometrix Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。